US seeks injunction on Indian drug firm Ranbaxy
US officials sought a "groundbreaking" injunction against Indian drug giant Ranbaxy on Wednesday, saying the maker of the first generic version of cholesterol-lowering Lipitor has failed to meet US safety guidelines.
The filing, which would require Ranbaxy to stop selling drugs made at four of its manufacturing plants until it remedies deviations from current good manufacturing practices, could trigger multi-million-dollar repercussions as Ranbaxy's drug had been one of the most hotly anticipated rollouts of a generic when it hit the US market late last year.
The Justice Department, citing manufacturing and data integrity shortcomings, said that US food safety authorities want to block the company from doing business here because its actions made "many of Ranbaxy's drugs adulterated, potentially unsafe and illegal to sell in the United States."
The US Food and Drug Administration (FDA) gave the Indian firm the go-ahead last November to make a generic version of Lipitor, which was the best-selling drug of all time and earned US pharma giant Pfizer $100 billion after coming on the market in 1997.
Pfizer's patent on Lipitor -- atorvastatin calcium -- expired at the end of November.
Ranbaxy, which is majority owned by Japan's Daiichi, had faced delays in gaining FDA approval due to problems with quality control at some of its Indian and US factories.
Those problems came into sharp focus Wednesday with the department's filing, made at the request of the FDA, against India's Ranbaxy Laboratories -- and its US subsidiary Ranbaxy Inc -- in US District Court outside the capital Washington.
"This action against Ranbaxy is groundbreaking in its international reach," Tony West, assistant attorney general for the Justice Department's Civil Division, said in a statement.
"It requires the company to make fundamental changes to its plants in both the United States and India," he added.
"Our commitment to ensuring that the drugs the American people rely on are safe, effective and manufactured according to the FDA's standards extends beyond our borders."
If and when the decree is approved by the court, "it becomes a court order with which Ranbaxy must comply or face contempt," the Justice Department said.
The Justice Department listed several problems, including "inadequate testing of drugs to ensure that they kept their strength and effectiveness until their expiration date."
In addition, "Ranbaxy submitted false data in drug applications to the FDA, including the backdating of tests and the submitting of test data for which no test samples existed," it added.
According to the consent decree, Ranbaxy must hire a third party expert to conduct an internal review at the facilities; implement procedures and controls to ensure data integrity; and withdraw any applications found to contain untrue statements or data irregularities that could affect application approval.
In a separate statement, FDA said it took action to protect consumers.
"This company continued to violate current good manufacturing practice regulations and falsify information on drug applications," said Dara Corrigan, the FDA's associate commissioner for regulatory affairs.
"The FDA continues to be committed to protecting consumers from potentially unsafe products that may be offered on the market."
It said notably that Ranbaxy's drugs would be barred from the US market as well as inclusion in the US President's Emergency Plan for AIDS Relief (PEPFAR) program "until drugs can be manufactured at such facilities in compliance with US manufacturing quality standards."
Ranbaxy said it had signed the consent decree in December ahead of the filing, and that the company was committed to strengthening procedures and policies.
"Separately, Ranbaxy also announced that it intends to make a provision of $500 million in connection with the investigation by the US Department of Justice, which the company believes will be sufficient to resolve all potential civil and criminal liability," it said.
In the United States, anti-cholesterol drugs account for 255 million prescriptions a year, and about nine million people are taking Lipitor.
US-based Watson Pharmaceuticals announced its launch of a generic version of Lipitor under an exclusive supply and distribution agreement with Pfizer, whereby Pfizer manufactures the drug and Watson sells it, sharing net sales with Pfizer until 2016.
The FDA said it recommends that patients taking Ranbaxy-produced drugs maintain their drug therapy, but speak with their doctors.
(c) 2012 AFP
- US approves India's Ranbaxy to make generic Lipitor Dec 01, 2011 | not rated yet | 0
- Pfizer's blockbuster drug Lipitor goes generic Nov 30, 2011 | not rated yet | 0
- Pfizer maneuvers to protect Lipitor from generics Nov 29, 2011 | not rated yet | 0
- With new generic rivals, Lipitor's sales halved Dec 20, 2011 | not rated yet | 0
- Heart defibrillator company signs decree May 01, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
18 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications May 17, 2013 | not rated yet | 0
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications May 17, 2013 | 5 / 5 (1) | 0
(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...
Medications May 16, 2013 | 3.5 / 5 (2) | 0 |
(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...
Medications May 15, 2013 | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
11 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
9 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
9 hours ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
19 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
20 hours ago | 5 / 5 (1) | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
11 hours ago | 5 / 5 (2) | 0